QA: Paratek Pharmaceuticals Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2018_Paratek_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 160,486,000
1 IntangibleAssetsNetIncludingGoodwill 971,000
2 PropertyPlantAndEquipmentNet 1,711,000
3 remainder_Assets 530,000
4 LiabilitiesCurrent 16,789,000
5 LiabilitiesNoncurrent 64,360,000
6 remainder_Liabilities 71,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,965,000
9 ResearchAndDevelopmentExpense 60,072,000
10 remainder_Expenses 5,991,000
11 remainder_Revenues 12,616,000
12 remainder_NetIncome 1,343,000
13 remainder_ComprehensiveNetIncome -142,000
  yvar yval
0 Assets 163,698,000
1 Liabilities 81,220,000
2 Expenses 103,028,000
3 Revenues 12,616,000
4 StockholdersEquity 82,478,000
5 NetIncome -89,069,000
6 ComprehensiveNetIncome -89,140,000
7 BaseVar 181,023,500
8 EconomicCapitalRatio 0.431

Edgar->Model Mapping

Feature Distribution

Change over Time